CD79A and infection: As IgA-producing plasma cells are mainly located at mucosal sites, this suggests that MTBVAC may be capable of inducing a mucosal immune response which could be beneficial in protecting against infection with M.tb which primarily invades the host through the mucosal surfaces of the respiratory tract.